PDGF-BB Preserves Mitochondrial Morphology, Attenuates ROS Production, and Upregulates Neuroglobin in an Astrocytic Model Under Rotenone Insult
dc.creator | Cabezas R. | |
dc.creator | Vega-Vela N.E. | |
dc.creator | González-Sanmiguel J. | |
dc.creator | González J. | |
dc.creator | Esquinas P. | |
dc.creator | Echeverria V. | |
dc.creator | Barreto G.E. | |
dc.date.accessioned | 2020-09-02T22:13:43Z | |
dc.date.accessioned | 2022-11-08T20:20:10Z | |
dc.date.available | 2020-09-02T22:13:43Z | |
dc.date.available | 2022-11-08T20:20:10Z | |
dc.date.created | 2020-09-02T22:13:43Z | |
dc.date.issued | 2018 | |
dc.identifier | 55, 4, 3085-3095 | |
dc.identifier | 08937648 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3853 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143469 | |
dc.language | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | Astrocytes | |
dc.subject | Mitochondria | |
dc.subject | Neuroglobin | |
dc.subject | PDGF-BB | |
dc.subject | Reactive oxygen species | |
dc.subject | Rotenone | |
dc.subject | cytoskeleton protein | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | neuroglobin | |
dc.subject | platelet derived growth factor BB | |
dc.subject | reactive oxygen metabolite | |
dc.subject | rotenone | |
dc.subject | biological marker | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | neuroglobin | |
dc.subject | phosphatidylinositol 3 kinase | |
dc.subject | platelet derived growth factor | |
dc.subject | protein kinase B | |
dc.subject | reactive oxygen metabolite | |
dc.subject | rotenone | |
dc.subject | antioxidant activity | |
dc.subject | Article | |
dc.subject | astrocyte | |
dc.subject | cell protection | |
dc.subject | cell structure | |
dc.subject | cell ultrastructure | |
dc.subject | controlled study | |
dc.subject | mitochondrion | |
dc.subject | oxidative stress | |
dc.subject | protein expression | |
dc.subject | protein function | |
dc.subject | upregulation | |
dc.subject | astrocyte | |
dc.subject | cytoskeleton | |
dc.subject | drug effect | |
dc.subject | human | |
dc.subject | metabolism | |
dc.subject | mitochondrion | |
dc.subject | signal transduction | |
dc.subject | tumor cell line | |
dc.subject | ultrastructure | |
dc.subject | upregulation | |
dc.subject | Astrocytes | |
dc.subject | Biomarkers | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cytoskeleton | |
dc.subject | Humans | |
dc.subject | Mitochondria | |
dc.subject | Neuroglobin | |
dc.subject | NF-kappa B | |
dc.subject | Phosphatidylinositol 3-Kinases | |
dc.subject | Platelet-Derived Growth Factor | |
dc.subject | Proto-Oncogene Proteins c-akt | |
dc.subject | Reactive Oxygen Species | |
dc.subject | Rotenone | |
dc.subject | Signal Transduction | |
dc.subject | Up-Regulation | |
dc.title | PDGF-BB Preserves Mitochondrial Morphology, Attenuates ROS Production, and Upregulates Neuroglobin in an Astrocytic Model Under Rotenone Insult | |
dc.type | Article |